Marizyme (MRZM, $0.05) was one of the top gainers for the month, rising +5 to $0.05 per share. A.I.dvisor analyzed 865 stocks in the Biotechnology Industry for the month ending September 24, 2024 and discovered that of them (4) exhibited an Uptrend while of them (5) exhibited a Downtrend.